Research
Another SARS-CoV-2 laboratory diagnostic has caught the attention of the Biomedical Advanced Research and Development Authority (BARDA), which is teaming up with OraSure Technology, Inc. to get it United States Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
This test,... Read More »
For three years, the Biomedical Advanced Research and Development Authority (BARDA) has supported the development of Chembio Diagnostics’ DPP Zika IgM System diagnostic system, and now, the result has been approved for marketing by the U.S. Food and Drug Administration.
The test detects... Read More »
U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) inventors John Neilan and Michael Puckette have come up with a breakthrough to treat foot-and-mouth disease (FMD) in livestock.
FMD is a disease that is extremely contagious and afflicts animals with cloven... Read More »
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has earmarked $3.9 million to fund small business research for homeland security technology needs assessment.
The agency has awarded 26 competitive research contracts to 23 small businesses participating in Phase... Read More »
A highly anticipated University of Minnesota study examining the use of hydroxychloroquine among young health care workers found the drug does not prevent symptoms of COVID-19.
The randomized trial primarily examined the use of the drug on 821 young participants with a median age of 40, who... Read More »
The University of Queensland (UQ) has partnered up with CSL and the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate development, manufacturing, and distribution of a COVID-19 vaccine candidate its researchers pioneered earlier this year.
In an agreement formalized this week,... Read More »
Results are in from the phase 1 human trial of the Bavarian Nordic A/S vaccine candidate MVA-BN WEV, a prophylactic meant for use against three equine encephalitis viruses, and the data paints the picture of a well-tolerated vaccine capable of spurring immune responses.
The vaccine is meant to... Read More »
A coalition of AbbVie, Harbour BioMed (HBM), Utrecht University (UU), and Erasmus Medical Center (EMC) have joined together to create a monoclonal antibody therapy that could hold the key to preventing and treating COVID-19, through its viral cause: SARS-CoV-2.
The therapeutic is based on a... Read More »
As part of an expansion to their existing partnership, the Biomedical Advanced Research and Development Authority (BARDA) and MODERNATX, Inc. will increase the domestic manufacturing capacity of the mRNA-1273 vaccine, a candidate to stop the spread of COVID-19.
The relationship has been ongoing... Read More »
A report by the U.S. Government Accountability Office (GAO) examines how federal agencies use infectious disease modeling to fight outbreaks and what can be done to improve them.
The report, titled “Infectious Disease Modeling: Opportunities to Improve Coordination and Ensure... Read More »
As part of a validation study, the U.S. Food and Drug Administration (FDA) publicly posted test performance data from four antibody test kits this week.
This independent performance validation effort is being undertaken alongside the National Institutes of Health’s National Cancer Institute... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to develop a Chikungunya vaccine, providing as much as $14.1 million for manufacturing and clinical development.
On the line is a two-dose,... Read More »
First responders and healthcare workers stand to benefit from a new partnership between the Biomedical Advanced Research and Development Authority (BARDA) and Evidation Health, which are sifting through data from wearable devices to create an early warning algorithm for COVID-19 symptoms.
This... Read More »
Scientists and engineers at Texas A&M University are developing a device that can rapidly identify antibodies that can neutralize infection by SARS-CoV-2, the virus that causes COVID-19.
"The difficulty of developing therapeutics and vaccines against emerging viral threats can also be obviously... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is working with Quidel Corp. to develop to detect COVID-19 and three additional respiratory viruses.
The two will work together to develop a rapid multi-analyte diagnostic test for use on the Sofia 2 assay system to detect the... Read More »
The latest addition to the Biomedical Advanced Research and Development Authority’s (BARDA) COVID-19 countermeasure portfolio is an automated total antibody test being developed in partnership with Siemens Healthineers.
The serological, lab-based test proposes to detect two items in human... Read More »
The Government Accountability Office (GAO) recently delivered testimony maintaining the lack of foreign drug manufacturer inspections removes critical information about the quality of drugs manufactured for markets here.
The GAO said the Food and Drug Administration (FDA) began postponing almost... Read More »
BAE Systems said it has completed the initial test of its APKWS laser-guided rockets from a tactical configuration ground-based weapon system.
“Our customers see the value in low-cost, precision-strike capabilities that reduce the risk of collateral damage, and they want the flexibility to... Read More »
A partnership between the Biomedical Advanced Research and Development Authority (BARDA) and biotechnology company Genentech will yield a phase 2 clinical trial to evaluate two investigational drugs for the treatment of severe COVID-19 cases: anti-ST2 and IL-22-Fc.
The drugs will be tested on... Read More »
More than 30 countries and international partners/institutions have rallied behind the COVID-19 Technology Access Pool (C-TAP), a new initiative from the World Health Organization (WHO) and Costa Rica designed to make scientific tools to fight COVID-19 universally available.
The show of unity... Read More »
Defense Advanced Research Projects Agency (DARPA) officials said a pair of California-based firms have been selected to participate in its Gamma Ray Inspection Technology (GRIT) program to aid medical applications.
Lumitron Technologies and RadiaBeam Technologies have initiated efforts to... Read More »
Chimeron Bio and George Mason University's National Center for Biodefense and Infectious Diseases (NCBID) are teaming up to develop a COVID-19 vaccine.
The vaccine development will be based on Chimeron Bio's ChaESARTM self-amplifying RNA technology. Plus, it will integrate Mason's complimenting... Read More »
The Department of Defense (DoD) recently announced that two entities are collaborating to build and test a fifth-generation (5G) cellular network.
The Office of the Under Secretary of Defense for Research and Engineering (OUSD(R&E)) and the U.S. Air Force Warfare Center (USAFWC) are partnering... Read More »
Under a $4.6 million contract with the Defense Threat Reduction Agency (DTRA) and Defense Innovation United (DIU), PercuSense has been tapped to develop a continuous biosensor system for early detection of potential toxic chemical exposure among soldiers and first responders.
PercuSense, a... Read More »
A phase 3 clinical trial that will utilize a mix of Actemra/RoActemra and remdesivir on hospitalized COVID-19 patients with severe pneumonia is expected to begin in June, as part of a collaboration between Roche and Gilead Sciences, Inc.
That trial, REMDACTA, will be double-blind, randomized,... Read More »
A new reference panel being offered by the U.S. Food and Drug Administration (FDA) proposes an additional, independent validation step to guarantee the quality of COVID-19 diagnostic tests.
Since COVID-19 reached U.S. shores earlier this year, many tests have arisen to detect its viral cause:... Read More »
Recent findings from a NORC at the University of Chicago study have determined if a COVID-19 vaccine becomes available, 49 percent of respondents said they plan to get vaccinated.
The nationwide poll was conducted May 14-18, 2020, via the AmeriSpeak Panel - the probability-based panel of NORC at... Read More »
The U.S. Government Accountability Office (GAO) released a report detailing the process of developing a COVID-19 vaccine.
The United States government is funding multiple efforts to develop vaccines. GAO said it is an expensive, lengthy process that involves a series of steps first to identify... Read More »
Merck announced a series of actions against COVID-19 this week, joining the fight against the global pandemic through two agreements that further potential vaccines against its viral source, SARS-CoV-2, and a research collaboration intended to create a novel antiviral candidate.
“With our... Read More »
A COVID-19 vaccine candidate created by Novavax, Inc. and supported by the Coalition for Epidemic Preparedness Innovations (CEPI) began clinical trials this week, with the enrollment of participants in a Phase 1/2 study.
The vaccine in question is called NVX-CoV2373, a stable, prefusion protein... Read More »
A preliminary report on data from the Adaptive COVID-19 Treatment Trial, published in the New England Journal of Medicine last week, showed positive potential for remdesivir as a treatment for COVID-19.
The randomized, controlled trial, sponsored by the National Institute of Allergy and... Read More »
It is past time for a national COVID-19 vaccine plan from the Trump administration, according to House Energy and Commerce Committee leaders so that the country can plan for development, manufacturing, distribution, training, and education linked to these efforts, along with broad vaccine... Read More »
A group of Republican senators introduced legislation requires national security evaluation and clearance for all Chinese student visa holders taking part in activities related to COVID-19 vaccine research.
The COVID-19 Vaccine Protection Act – sponsored by Sens. Martha McSally (R-AZ), Rick... Read More »
Through its COVID-Local site, the Nuclear Threat Initiative (NTI) has released a guide of new metrics meant to guide local leaders and state officials in safely reopening the United States.
The site now includes interactive graphics and downloadable PDFs, meant to aid assessment of existing... Read More »
Recognizing the dangers presented by COVID-19 to the elderly and immunocompromised in particular, the Biomedical Advanced Research and Development Authority (BARDA) has partnered with VitalConnect to create a wearable monitor that could provide early warning signs and improve patient... Read More »
